Retrospective Chart Review of Treatment Patterns, Healthcare Resource Utilization in Patients With Severe Aplastic Anemia and Poor Response to Immunosuppression

December 9-12, 2017; Atlanta, Georgia
Initiation of eltrombopag reduced mean number of transfusions and healthcare resource utilization rates vs before eltrombopag administration.
Format: Microsoft PowerPoint (.ppt)
File Size: 238 KB
Released: December 14, 2017


This activity is supported by educational grants from
Novartis Pharmaceuticals Corporation

Related Content

Dr. Robin L. Jones offers expert commentary on TKI therapy in advanced osteosarcoma and nonadipocytic sarcoma, from Clinical Care Options (CCO)

Robin L. Jones, BSc, MBBS, MRCP, MD(Res) Released: May 25, 2022

A video on providing respectful healthcare for transgender persons as illustrated through the personal transition story of Pharmacist Olivia Buckoski, from Clinical Care Options (CCO)

Olivia Buckoski, PharmD Released: May 25, 2022

Downloadable resource: current EGFR-targeted agents for advanced NSCLC with EGFR mutations, including exon 20 insertions, from Clinical Care Options (CCO)

Released: May 24, 2022

Downloadable resource on active research and ongoing clinical trials in EGFR-mutated NSCLC, from Clinical Care Options (CCO)

Released: May 24, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings